Lali, Baby Boy .
HRN: 22-82-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2023
AMPICILLIN 250MG (VIAL)
04/09/2023
04/15/2023
IV
125mg
Q12hr
Neonatal Asphyxia
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes